Linker
Showing 26 - 50 of 155
Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)
Recruiting
- Large B-cell Lymphoma
- DLBCL
- 89Zr-DFO-REGN3767
- PET/CT
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 3, 2022
Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)
Terminated
- Acute Lymphocytic Leukemia
- Adult Lymphoblastic Lymphoma
- DNR
- +12 more
-
La Jolla, California
- +3 more
Apr 26, 2022
Chronic Kidney Disease, Dialysis, Kidney Transplant Trial in Danville (Observational study - registry)
Recruiting
- Chronic Kidney Disease
- +3 more
- Observational study - registry
-
Danville, PennsylvaniaGeisinger Clinic
Aug 9, 2022
Axial Spondyloarthritis, Psoriatic Arthritis Trial in Istanbul (serum raftlin-1 protein levels)
Recruiting
- Axial Spondyloarthritis
- Psoriatic Arthritis
- serum raftlin-1 protein levels
-
Istanbul, TurkeyBezmialem University
Mar 22, 2023
HIV Trial in United States (FP conjugate vaccine (25 mcg), FP conjugate vaccine (200 mcg), Trimer 6931 (100 mcg))
Not yet recruiting
- HIV
- FP conjugate vaccine (25 mcg)
- +5 more
-
Los Angeles, California
- +6 more
Jul 19, 2022
Breast Cancer Trial in China (TQB2102 for injection)
Not yet recruiting
- Breast Cancer
- TQB2102 for injection
-
Hefei, Anhui, China
- +20 more
Nov 1, 2023
Home Environment of Patients With Multiple Sclerosis
Recruiting
- Multiple Sclerosis
-
Regensburg, Bavaria, GermanyDepartment of Neurology, University of Regensburg
Apr 12, 2021
Heart Failure With Preserved Ejection Fraction Trial in Madrid
Recruiting
- Heart Failure With Preserved Ejection Fraction
-
Madrid, SpainHospital Universitario Ramón y Cajal
Aug 16, 2023
Metastatic Breast Cancer Trial in Japan, United States (Patritumab Deruxtecan)
Active, not recruiting
- Metastatic Breast Cancer
- Patritumab Deruxtecan
-
Newnan, Georgia
- +25 more
Dec 5, 2022
Myoma;Uterus, IVF, Surgery Trial (myomectomy or not)
Not yet recruiting
- Myoma;Uterus
- +2 more
- myomectomy or not
- (no location specified)
Jul 6, 2023
Heart Failure Trial in Worldwide (Quadripolar LV Lead)
Recruiting
- Heart Failure
- Quadripolar LV Lead
-
Anchorage, Alaska
- +114 more
Aug 9, 2022
Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)
Not yet recruiting
- Stem Cell Transplant Complications
- Eltrombopag 25 MG Oral Tablet
- Thrombopoietin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 17, 2022
Urothelial Carcinoma Trial in Milan (Sacituzumab govitecan)
Recruiting
- Urothelial Carcinoma
- Sacituzumab govitecan
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 7, 2022
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)
Recruiting
- Epithelial Ovarian Cancer
- +2 more
- Mirvetuximab Soravtansine
-
Bengbu, Anhui, China
- +27 more
Nov 14, 2022
Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab-Deruxtecan (T-DXd)
- (no location specified)
Sep 20, 2023
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, NSCLC Stage IV Trial in Australia, United States (IMU-201
Recruiting
- Non Small Cell Lung Cancer
- +5 more
- IMU-201 (administered as PD1-Vaxx)
-
Phoenix, Arizona
- +5 more
Jan 19, 2022
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)
Completed
- Epithelial Ovarian Cancer
- +2 more
- Mirvetuximab Soravtansine
-
Phoenix, Arizona
- +88 more
Jan 19, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in United States (U3-1402)
Recruiting
- Metastatic Breast Cancer
- Locally Advanced Breast Cancer
-
Birmingham, Alabama
- +9 more
Jul 18, 2022
Immune System Diseases Trial (Strimvelis)
Withdrawn
- Immune System Diseases
- Strimvelis
- (no location specified)
Jul 13, 2020
Severe Pneumonia Trial in Changzhou, Nanjing, Suzhou (SSBD(PCR-CRISPR/Cas12a))
Not yet recruiting
- Severe Pneumonia
- SSBD(PCR-CRISPR/Cas12a)
-
Changzhou, Jiangsu, China
- +4 more
May 8, 2022